Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Benchtop Bioreactors Market Forecast: What Value Will The Market Reach By 2030?
The benchtop bioreactors market has seen swift expansion in recent years. Its valuation is expected to rise from $1.08 billion in 2025 to $1.19 billion in 2026, registering a compound annual growth rate (CAGR) of 10.2%. The previous period’s growth was primarily due to increased funding in life sciences research, the expansion of academic and research institutions, the reliance on small-scale fermentation systems, a rise in pharmaceutical R&D endeavors, and the escalating need for regulated laboratory settings.
The benchtop bioreactors market size is anticipated to experience substantial expansion over the upcoming years. It is projected to reach $1.75 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. This projected growth during the forecast period is fueled by several factors, including the increasing development of biologics and biosimilars, the embrace of automated and continuous bioreactors, a heightened emphasis on personalized medicine research, growing partnerships with Contract Research Organizations (CROs), and innovations in bioprocessing technologies. Key developments expected in this period encompass the increasing integration of benchtop bioreactors into research and development activities, a surge in demand for single-use and modular bioreactor systems, a concentrated effort on refining processes and boosting yield, an expansion of cell culture and microbial fermentation investigations, and a growing application of benchtop bioreactors in educational and academic settings.
Get A Free Sample Report With In-Depth Market Insights:
Benchtop Bioreactors Market Growth Backed By Core Demand Fundamentals
The increasing integration of gene therapies is anticipated to drive expansion within the benchtop bioreactors market in the future. Gene therapy is defined as a medical approach where faulty genes are altered or substituted to address or avert illnesses. Growing interest in gene therapy stems from progress in genetic sequencing and diagnostics, facilitating accurate detection of disease-related genes for focused interventions. Benchtop bioreactors enhance gene therapies by providing precise regulation and effective manufacturing of cells modified by genes. These devices facilitate quick research and limited-scale production, thereby boosting operational speed and uniformity. As an illustration, data from December 2024, supplied by the American Society of Gene & Cell Therapy (ASGCT), a non-profit medical and scientific body based in the US, showed that the Food and Drug Administration (FDA) gave its approval to six gene therapy products in 2023, an increase from five approvals recorded in 2022. Consequently, the expanding use of gene therapies is stimulating the development of the benchtop bioreactors market.
Benchtop Bioreactors Market Segment Breakdown: Which Categories Lead On Revenue?
The benchtop bioreactors market covered in this report is segmented –
1) By Type: Swing-Style Bioreactors, Stirred-Tank Bioreactors, Wave-Mixed Bioreactors, Airlift Bioreactors, Bubble Column Bioreactors
2) By Control Type: Automated Bioreactors, Manual Bioreactors, Continuous Bioreactors, Batch Bioreactors
3) By Material: Stainless Steel, Glass, Plastic, Composite Materials
4) By Application: Research And Development, Process Development, Bioproduction, Quality Control, Training And Education
5) By End User: Pharmaceutical Companies, Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations (CROs), Food And Beverage Industry
Subsegments:
1) By Swing-Style Bioreactors: Single-Use Swing Bioreactors, Multi-Use Swing Bioreactors, Compact Swing Bioreactors, Automated Swing Bioreactors
2) By Stirred-Tank Bioreactors: Single-Use Stirred-Tank Bioreactors, Glass Stirred-Tank Bioreactors, Stainless-Steel Stirred-Tank Bioreactors, Modular Stirred-Tank Bioreactors, Automated Stirred-Tank Bioreactors
3) By Wave-Mixed Bioreactors: Single-Use Wave-Mixed Bioreactors, Dual-Motion Wave-Mixed Bioreactors, Automated Wave-Mixed Bioreactors, Compact Wave-Mixed Bioreactors
4) By Airlift Bioreactors: Internal Loop Airlift Bioreactors, External Loop Airlift Bioreactors, Single-Use Airlift Bioreactors
5) By Bubble Column Bioreactors: Vertical Bubble Column Bioreactors, Single-Use Bubble Column Bioreactors, Gas-Lift Bubble Column Bioreactors, Automated Bubble Column Bioreactors
Benchtop Bioreactors Market Growth Trends Reshaping The Competitive Landscape
Leading companies within the benchtop bioreactors market are focusing on creating innovative solutions, such as benchtop fermenters, to enhance precise control and scalability for research and small-scale production. Benchtop fermenters are compact, laboratory-scale bioreactors designed for the controlled cultivation of microorganisms or cells, supporting both research and limited production needs. For instance, in September 2024, VFL Sciences Private Limited, an India-based biotechnology equipment manufacturer, introduced the GreatFlo range of benchtop fermenters or bioreactors. This versatile and modular product line is engineered to allow easy scale-up and consistent reproducibility in fermentation and cell culture applications. These fermenters support seamless parallel operation with flexible expansion options, ranging from 2 to 16 vessels, each providing a working volume of 200-500 ml. They are equipped with Peltier-controlled heating and cooling, exhaust condensers, and software that complies with 21 CFR Part 11, offering precise regulation of agitation, pH, dissolved oxygen, and individual gas mixing.
Benchtop Bioreactors Market Leading Players And Competitive Positioning
Major companies operating in the benchtop bioreactors market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE Healthcare, Sartorius AG, Eppendorf AG, Solaris Biotech Solutions, IKA-Werke GmbH And Co. KG, GPC Bio USA, Praj HiPurity Systems Limited., PBS Biotech Inc., Bioengineering AG, Broadley-James Ltd., Infors HT, Solida Biotech, Bbi-biotech GmbH, Applikon Biotechnology B.V., Labfirst Scientific Instruments Co. Ltd, Pharsol Ltd., Uma Pharmatech Machinery
View The Full Benchtop Bioreactors Market Report:
Benchtop Bioreactors Market Regional Distribution: Which Areas Power Market Growth?
North America was the largest region in the benchtop bioreactors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the benchtop bioreactors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model